Reunion Neuroscience (TSX:REUN) Operating Cash Flow per Share : C$-2.40 (TTM As of Mar. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Reunion Neuroscience Operating Cash Flow per Share?

Reunion Neuroscience's operating cash flow per share for the three months ended in Mar. 2023 was C$-0.38. Reunion Neuroscience's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2023 was C$-2.40.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Reunion Neuroscience's Operating Cash Flow per Share or its related term are showing as below:

TSX:REUN's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.6
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Reunion Neuroscience Operating Cash Flow per Share Historical Data

The historical data trend for Reunion Neuroscience's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reunion Neuroscience Operating Cash Flow per Share Chart

Reunion Neuroscience Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Operating Cash Flow per Share

-0.25

-2.56

-3.83

-2.40

Reunion Neuroscience Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Operating Cash Flow per Share	Get a 7-Day Free Trial										-0.83	-0.92	-0.72	-0.38	-0.38

Competitive Comparison of Reunion Neuroscience's Operating Cash Flow per Share

For the Biotechnology subindustry, Reunion Neuroscience's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Reunion Neuroscience's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Reunion Neuroscience's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Reunion Neuroscience's Price-to-Operating-Cash-Flow falls into.

Reunion Neuroscience Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Reunion Neuroscience's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )	=	Cash Flow from Operations (A: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2023 )
	=	-27.917	/	11.641
	=	-2.40

Reunion Neuroscience's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2023 )	=	Cash Flow from Operations (Q: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2023 )
	=	-4.421	/	11.646
	=	-0.38

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.40

Reunion Neuroscience Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Reunion Neuroscience's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Reunion Neuroscience (TSX:REUN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Reunion Neuroscience Inc (TSX:REUN) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 Duncan Street, Lower North Suite, Toronto, ON, CAN, M5V 2C3

Website

https://www.reunionneuro.com

Reunion Neuroscience Inc is engaged in novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company's asset, RE-104 (previously known as FT-104), is a proprietary, novel psychedelic drug being developed for post-partum and treatment-resistant depression as a potential fast-acting antidepressant with durable efficacy.